Charles River Laboratories Germany

• 2025 UNCOVERING THERAPEUTIC VULNERABILITIES IN PEDIATRIC BCOR/L1-DRIVEN CNS TUMORS THROUGH MULTI-OMICS PROFILING

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format